In the UK, access to Tirzepatide (Mounjaro), a weight loss injection, through primary care services is planned to begin in June 2025. The NHS has allocated funding based on obesity prevalence rates at the Integrated Care Board (ICB) level to cover the drug and its management. 

Eligibility Criteria:

• BMI:

A Body Mass Index (BMI) of 35 or higher, or 32.5 or higher if you are of Asian, Chinese, Middle Eastern, Black African, or African-Caribbean origin. 

• Weight-Related Health Conditions:

At least one other weight-related illness, such as type 2 diabetes, high blood pressure, or cardiovascular disease, Obstructive Sleep Apnoea.  

• Other Medical Conditions:

In some cases, individuals with a BMI below 35 may be eligible if they have type 2 diabetes and using insulin would affect their job due to the risk of hypoglycaemia, or if weight loss would lead to improvements in other obesity-related health issues. 

Phased Implementation:

• The NHS is implementing a phased approach to Tirzepatide access over three years. 
• Priority will be given to patients with a BMI of 40 or more, with four qualifying comorbidities, in the first year. 
• In the second year (2026/27), people with a BMI of 35-39.9 and four qualifying comorbidities will be eligible. 
• The total eligible population is expected to have access within 12 years, based on cohort prioritization. 
• Local Integrated Care Boards (ICBs) are responsible for funding and managing Tirzepatide access in primary care settings, starting June 23, 2025. 
• We are waiting for further guidance from the Redbridge ICB about this and will provide any updates when available.

Important Notes:

• Access to Tirzepatide will be offered in a phased manner, with priority given to specific patient cohorts based on clinical need. 

Due to long NHS waits we recognise that you may choose to have your ADHD assessment undertaken by a non NHS provider ie privately. As this is specialist work if you are then recommended medication please be aware that your GP will not be able to prescribe this medication via the NHS.

NOTICE OF ADHD and Gender re-assignment SCHARED CARE AGREEMENT POLICY

We are pleased to introduce Woodford Eye Clinic, an eye care provider in the East London/Essex area, offering services under the Minor Eye Care Scheme (MECS) for Redbridge and surrounding areas. We are actively accepting appointments, referrals, and walk-ins, even from outside the borough. What Does This Mean? Woodford Eye Clinic can triage and treat ANY eye-related problems, from minor to major conditions, with no need to visit GPs, pharmacies, A&E, or eye hospitals. Our trained optometrists provide fast and accurate diagnosis and treatment, reducing pressure on other healthcare providers and significantly improving patient waiting times.

Download the latest NHS App update.

The NHS App has been redesigned to make it simpler and easier to access NHS services.

Some items have moved within the App, but all the health services you need are still available. Your settings will remain the same before and after the update too. 

The new, user-friendly version of the NHS App will start to be available from December 11th, making it easier to: 

• order repeat prescriptions 
• book appointments 
• access 111 Online
• view your GP record
• and much more…

Need some help using the NHS App? Use the in-app Help feature or visit nhs.uk/nhs-app for guidance.

Instant and 24/7 access to a personalised programme 

Do you have a joint or muscle problem?  

Is it affecting your

Back
Back & Leg
Neck
Shoulder
Elbow
Hip
Knee
Ankle
Sprains and strains - leg
Upper Limb Tendinopathy
Lower Limb Tendinopathy

Please use the FREE getUBetter app designed and written by your local clinicians in
North East London - BHR. It offers tips, advice, and exercises tailored to
you and your stage of recovery.

Patients can start safely self-managing from day one of an injury.

Enter your email here on the "getUbetter" website to sign up and download the app to get started